By elucidating the role of purinergic signalling in macrophage-driven atherosclerosis and highlighting the therapeutic potential of targeting P2Y6 receptors, this study provides valuable insights that could guide future clinical interventions for atherosclerosis treatment. The gene discussed is P2RY6; the disease is atherosclerosis.